Egan James 4

4 · Sucampo Pharmaceuticals, Inc. · Filed Sep 28, 2009

Form 4

Period: 2009-09-14

Chief Operating Officer

Transactions

Award
Employee Stock Option (Right to buy)
2009-09-16+7,000→ 7,000 total
Exercise: $4.99Exp: 2019-09-16→ Class A common stock (7,000 underlying)
Award
Employee Stock Option (Right to buy)
2009-09-14+60,000→ 60,000 total
Exercise: $4.98Exp: 2019-09-14→ Class A common stock (60,000 underlying)
Award
Employee Stock Option (Right to buy)
2009-09-23+60,000→ 60,000 total
Exercise: $5.87Exp: 2019-09-23→ Class A common stock (60,000 underlying)

Footnotes (3)

[F1]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2010 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2011 in four equal annual installments.
[F2]Vesting commences on September 16, 2010 in four equal annual installments.
[F3]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2012 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2013 in four equal annual installments.

Documents

1 file